Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Teva Pharmaceutical Industries ADR
(NY:
TEVA
)
14.06
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Teva Pharmaceutical Industries ADR
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Roche Spends $7.1 Billion On Roivant Drug, Following Merck, Sanofi Into The Raging Hot Immunology Space
October 23, 2023
Roche is joining Merck and Sanofi in the TL1A drug space. These drugs could treat stomach diseases.
Via
Investor's Business Daily
Israeli-Hamas War: U.S. Exchange-Listed Israeli Stocks Continue To Decline
October 22, 2023
The 111 Israeli companies with stocks trading on US exchanges have combined market caps over $150B. Or at least they did midweek: since the Hamas-Israeli War began October 7th, pretty much everything...
Via
Talk Markets
Investor Exit Israel ETFs Following Attacks, But Remain Confident In Large-Caps
October 19, 2023
Israel-focused ETFs have plunged since the last trading day before Hamas launched surprise attacks on Israel, while some Israeli companies listed in the U.S. have so far escaped repercussions to their...
Via
Benzinga
Topics
ETFs
Thoughts For Thursday: War Worries Rattle The Market
October 19, 2023
Via
Talk Markets
Hamas-Israeli War: US Exchange Listed Israeli Stocks Hit Hard
October 18, 2023
111 Israeli companies trade on U.S. stock exchanges of which only 15 have market capitalization of $2B or more.
Via
Talk Markets
Israel Could Form Emergency Government: Defense Stocks, Israel ETFs In Focus During Conflict
October 10, 2023
As Israel ramps up its armed forces and a regional war with Hamas enters its fourth day, the country is considering forming an emergency government.
Via
Benzinga
Topics
ETFs
Israeli Stocks Fall as Investors Fear Middle East Conflict
October 09, 2023
The recent attacks on Israel will have a lasting economic impact. Here's what investors should know about Israeli stocks.
Via
InvestorPlace
Cathie Wood's ARK Israel Innovative Tech ETF Braces For Impact Amid Regional Warfare: 10 Stocks To Watch
October 09, 2023
Discover how Cathie Wood's ARK Israel Innovative Tech ETF responds to the Israel-Hamas conflict. Explore its portfolio performance and top Israeli stocks to watch amidst geopolitical turmoil.
Via
Benzinga
Topics
ETFs
Why Teva Pharmaceutical (TEVA) Stock Is Falling
October 09, 2023
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) shares are trading lower by 2.7% to $9.17 Monday morning amid conflict in the company's home country, Israel.
Via
Benzinga
Middle East War Hammers Israel-Based Stocks But Lifts Defense, Oil Names
October 09, 2023
Israel stocks, regardless of industry, sank Monday following the terrorist attack on Israel.
Via
Investor's Business Daily
Palantir And PwC Team Up To Accelerate Data-Driven Operations, OpenAI Rival Secures Billions In Big Tech Backing, Six US States Brace For Healthcare Strike: Today's Top Stories
October 04, 2023
Benzinga
Via
Benzinga
Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble.
October 04, 2023
The deal leans into the emerging TL1A drug class, potentially rivaling Roivant and Merck.
Via
Investor's Business Daily
Sanofi, Teva Pledge $1.5B To Target Inflammatory Bowel Disease That Impacts Almost 10M People
October 04, 2023
Sanofi SA (NASDAQ: SNY) and Teva Pharmaceutical Industries Ltd (NYSE: TEVA) have collaborated to co-develop and
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
Via
Benzinga
Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories
September 27, 2023
Benzinga Alibaba's Logistics Arm Cainiao Files For Hong Kong IPO
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Migraine Medication Battle: Eli Lilly Prevails in Patent Infringement Case Against Teva
September 27, 2023
A federal judge in Massachusetts has overturned a $176.5 million jury verdict against Eli Lilly And Co (NYSE: LLY). T
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Despite Efforts, Vulnerable Patients Still Face Barriers to Essential Medicines, Says New Report
September 26, 2023
Despite significant initiatives by generic drug companies to broaden access to vital medicines, many vulnerable patients remain underserved, according to findings from a new study from the Access to...
Via
Benzinga
3 No-Brainer Stocks to Buy With $20 Right Now
September 13, 2023
You don't need a boatload of cash to begin growing your wealth on Wall Street.
Via
The Motley Fool
Why Can't You Find Adderall? Inside the Ongoing Shortage of ADHD Medication In US
September 12, 2023
Last year, Teva Pharmaceutical Industries Ltd (NYSE: TEVA), the primary producer of Adderall, faced shortages
Via
Benzinga
TEVA - A Pharma Stock To Watch
September 11, 2023
TEVA is one of the few instruments that has handily cleared its July 6-month calendar range high. The 50 daily moving average is about to cross or golden cross the 200-DMA and enter a bullish phase.
Via
Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
September 11, 2023
Via
Benzinga
How A Small Indian Firm Firm Was Pulled Into A Legal Battle with Big Pharma Over A Cancer Drug
September 11, 2023
This story was first published on the Benzinga India portal.
Via
Benzinga
Bristol Myers' Antitrust Allegations: Lawsuit Over Alleged Patent Deception For Blood Cancer Drug
September 07, 2023
Bristol Myers Squibb Co (NYSE: BMY) faces fresh allegations in a recent lawsuit, accused of employing deceptive patents and illicit strategies to preserve its dominant position in the blood cancer drug...
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
S&P Slashes Ratings Of Five US Banks, SEC Fines Fintech Adviser Titan For Misleading Crypto Claims, Microsoft Modifies Activision Blizzard Purchase: Today's Top Stories
August 22, 2023
Benzinga
Via
Benzinga
Topics
Regulatory Compliance
Stocks
Exposures
Legal
Regulatory
US Equities
Big Pharma Price-Fixing: Teva and Glenmark's $255M Settlement Shines Light on Industry Issues
August 22, 2023
Drugmaker Teva Pharmaceutical Industries Limited (NYSE: TEVA) has
Via
Benzinga
FDA Greenlights Expanded Use Of Neurocrine Biosciences' Ingrezza: Analysts Weigh In Depression Warning
August 21, 2023
The FDA approved Neurocrine Biosciences Inc's (NASDAQ: NBIX) Ingrezza (valbenazine) capsules for the treatment of adults with chorea associated
Via
Benzinga
Exposures
Product Safety
Supreme Court Halts Purdue Pharma's $6B Settlement: Sackler Family's Shield From Opioid Lawsuits Challenged
August 10, 2023
On Thursday, the Supreme Court temporarily blocked a $6-billion bankruptcy settlement by Purdue Pharma, the maker of the opioid OxyContin, that would shield the Sackler family from civil lawsuits...
Via
Benzinga
Topics
Bankruptcy
Lawsuit
Exposures
Financial
Legal
Teva Pharmaceutical, Marathon Oil And 2 Other Stocks Insiders Are Selling
August 10, 2023
The Nasdaq 100 closed lower by over 1% on Wednesday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Teva Pharmaceutical Industries (TEVA) Q2 2023 Earnings Call Transcript
August 02, 2023
TEVA earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
August 02, 2023
Gainers WaveDancer, Inc. (NASDAQ: WAVD) shares climbed 86% to $0.5505. Tellenger, a subsidiary of Wavedancer, Inc., won a seven-year U.S. government contract.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.